| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 3.46e-05 | 2 | 118 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 4.26e-05 | 12 | 118 | 3 | GO:0050815 | |
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 1.03e-04 | 3 | 118 | 2 | GO:0008389 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 3.42e-04 | 5 | 118 | 2 | GO:0106294 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | RAG1 STUB1 RASA1 OXR1 SYNE1 HIP1R HMGB2 ADA YWHAH YWHAZ JUN AREL1 SQSTM1 PRKCQ ARHGEF2 MAP2K5 SFN AURKB NCKAP1L | 2.46e-05 | 1171 | 115 | 19 | GO:0043069 |
| GeneOntologyBiologicalProcess | positive regulation of RIG-I signaling pathway | 2.70e-05 | 11 | 115 | 3 | GO:1900246 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | RAG1 STUB1 RASA1 OXR1 SYNE1 HIP1R HMGB2 ADA YWHAH YWHAZ JUN AREL1 PRKCQ ARHGEF2 MAP2K5 SFN AURKB NCKAP1L | 5.44e-05 | 1133 | 115 | 18 | GO:0043066 |
| GeneOntologyBiologicalProcess | intracellular protein transport | VPS37A CLTCL1 HNF4A YWHAH GFAP MAP1LC3C PIK3C3 SQSTM1 PRKCQ KIF5C TMED10 ARHGEF2 SEC63 SFN | 6.46e-05 | 740 | 115 | 14 | GO:0006886 |
| Domain | 14_3_3 | 1.92e-10 | 7 | 118 | 5 | SM00101 | |
| Domain | 1433_1 | 1.92e-10 | 7 | 118 | 5 | PS00796 | |
| Domain | 1433_2 | 1.92e-10 | 7 | 118 | 5 | PS00797 | |
| Domain | 14-3-3_domain | 1.92e-10 | 7 | 118 | 5 | IPR023410 | |
| Domain | 14-3-3_CS | 1.92e-10 | 7 | 118 | 5 | IPR023409 | |
| Domain | 14-3-3 | 1.92e-10 | 7 | 118 | 5 | PF00244 | |
| Domain | 14-3-3 | 5.10e-10 | 8 | 118 | 5 | IPR000308 | |
| Domain | GABAAa_rho_rcpt | 3.96e-05 | 2 | 118 | 2 | IPR008057 | |
| Domain | DUOX1 | 3.96e-05 | 2 | 118 | 2 | IPR029595 | |
| Domain | TMEM191C | 3.96e-05 | 2 | 118 | 2 | PF15194 | |
| Domain | TMEM191B/C | 3.96e-05 | 2 | 118 | 2 | IPR028186 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 2.36e-04 | 4 | 118 | 2 | IPR008067 | |
| Domain | NAD_binding_6 | 8.14e-04 | 7 | 118 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 8.14e-04 | 7 | 118 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 8.14e-04 | 7 | 118 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 8.14e-04 | 7 | 118 | 2 | IPR013121 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 5.42e-09 | 12 | 85 | 5 | MM14482 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 5.42e-09 | 12 | 85 | 5 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 5.42e-09 | 12 | 85 | 5 | MM15443 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 8.40e-09 | 26 | 85 | 6 | M247 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 8.77e-09 | 13 | 85 | 5 | M27708 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 2.03e-08 | 15 | 85 | 5 | M26902 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 2.93e-08 | 16 | 85 | 5 | M46428 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 5.70e-08 | 18 | 85 | 5 | MM14510 | |
| Pathway | PID_P38_MK2_PATHWAY | 1.33e-07 | 21 | 85 | 5 | M199 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.78e-07 | 142 | 85 | 9 | MM15178 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.19e-07 | 23 | 85 | 5 | MM15216 | |
| Pathway | REACTOME_APOPTOSIS | 2.70e-07 | 108 | 85 | 8 | MM14471 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.10e-07 | 46 | 85 | 6 | M239 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 5.37e-07 | 211 | 85 | 10 | M27436 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 5.87e-07 | 12 | 85 | 4 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 5.87e-07 | 12 | 85 | 4 | M27939 | |
| Pathway | PID_NFAT_3PATHWAY | 7.35e-07 | 53 | 85 | 6 | M113 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 8.44e-07 | 13 | 85 | 4 | M47589 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 8.96e-07 | 30 | 85 | 5 | M17814 | |
| Pathway | REACTOME_APOPTOSIS | 1.26e-06 | 179 | 85 | 9 | M15303 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.99e-06 | 35 | 85 | 5 | M249 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 2.30e-06 | 36 | 85 | 5 | M271 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 3.19e-06 | 105 | 85 | 7 | M164 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 3.94e-06 | 40 | 85 | 5 | MM14473 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.99e-06 | 154 | 85 | 8 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 4.40e-06 | 156 | 85 | 8 | M39475 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 4.95e-06 | 73 | 85 | 6 | MM15223 | |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 6.81e-06 | 21 | 85 | 4 | M48088 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 8.29e-06 | 22 | 85 | 4 | MM15656 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 8.46e-06 | 80 | 85 | 6 | M223 | |
| Pathway | PID_LKB1_PATHWAY | 8.90e-06 | 47 | 85 | 5 | M87 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 1.02e-05 | 360 | 85 | 11 | M27267 | |
| Pathway | PID_FOXO_PATHWAY | 1.10e-05 | 49 | 85 | 5 | M136 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.12e-05 | 84 | 85 | 6 | M27495 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.25e-05 | 129 | 85 | 7 | M186 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 1.34e-05 | 51 | 85 | 5 | M7955 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 1.94e-05 | 55 | 85 | 5 | M7455 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 2.38e-05 | 257 | 85 | 9 | MM14755 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 4.74e-05 | 66 | 85 | 5 | MM15925 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 5.10e-05 | 67 | 85 | 5 | M295 | |
| Pathway | PID_MTOR_4PATHWAY | 5.87e-05 | 69 | 85 | 5 | M121 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 7.21e-05 | 72 | 85 | 5 | M26954 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 7.21e-05 | 72 | 85 | 5 | MM15381 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 8.77e-05 | 304 | 85 | 9 | MM14960 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 1.11e-04 | 126 | 85 | 6 | M16763 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.39e-04 | 323 | 85 | 9 | M27080 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 1.52e-04 | 327 | 85 | 9 | M27565 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 2.22e-04 | 143 | 85 | 6 | MM15383 | |
| Pathway | REACTOME_SARS_COV_1_INFECTION | 2.22e-04 | 143 | 85 | 6 | M39006 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.43e-04 | 93 | 85 | 5 | M27487 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 2.55e-04 | 94 | 85 | 5 | M1080 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.58e-04 | 147 | 85 | 6 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.98e-04 | 151 | 85 | 6 | M39329 | |
| Pathway | REACTOME_SARS_COV_1_HOST_INTERACTIONS | 3.10e-04 | 98 | 85 | 5 | M46424 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | VPS37A CLTCL1 HIP1R GDI2 YWHAB YWHAH YWHAZ RAB30 YWHAQ TMED10 COG4 SFN | 3.78e-04 | 630 | 85 | 12 | M11480 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 5.10e-04 | 167 | 85 | 6 | M19381 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | STUB1 HNF4A YWHAB YWHAH YWHAZ SMYD2 PSMD6 GLS CNOT7 ZFHX3 YWHAQ SFN AURKB | 6.54e-04 | 768 | 85 | 13 | MM14851 |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 6.68e-04 | 66 | 85 | 4 | M27938 | |
| Pathway | WP_CELL_CYCLE | 7.84e-04 | 120 | 85 | 5 | M39650 | |
| Pathway | KEGG_CELL_CYCLE | 9.42e-04 | 125 | 85 | 5 | M7963 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.24e-03 | 271 | 85 | 7 | MM15388 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 1.26e-03 | 9 | 85 | 2 | MM14833 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | VPS37A CLTCL1 HIP1R GDI2 YWHAB YWHAH YWHAZ RAB30 YWHAQ TMED10 COG4 SFN | 1.30e-03 | 725 | 85 | 12 | M27507 |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 1.44e-03 | 204 | 85 | 6 | M45011 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 1.57e-03 | 10 | 85 | 2 | M27120 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION | 1.57e-03 | 10 | 85 | 2 | M47745 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KALRN KTN1 YWHAB YWHAH YWHAZ PIK3C3 YWHAQ ARHGEF2 SFN AURKB NCKAP1L | 1.74e-03 | 649 | 85 | 11 | MM15690 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.86e-03 | 291 | 85 | 7 | M16647 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.91e-03 | 11 | 85 | 2 | M27130 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.28e-03 | 12 | 85 | 2 | MM14847 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 2.39e-03 | 93 | 85 | 4 | M27572 | |
| Pathway | REACTOME_AUTOPHAGY | 2.65e-03 | 158 | 85 | 5 | M27935 | |
| Pathway | WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS | 2.68e-03 | 13 | 85 | 2 | M39463 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION | 2.68e-03 | 13 | 85 | 2 | M47744 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 2.72e-03 | 159 | 85 | 5 | M39373 | |
| Pathway | WP_INSULIN_SIGNALING | 2.80e-03 | 160 | 85 | 5 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 2.80e-03 | 160 | 85 | 5 | M39482 | |
| Pubmed | 6.77e-13 | 11 | 120 | 6 | 15696159 | ||
| Pubmed | Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. | 9.39e-12 | 7 | 120 | 5 | 15023544 | |
| Pubmed | 9.39e-12 | 7 | 120 | 5 | 27030597 | ||
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 9.39e-12 | 7 | 120 | 5 | 20388496 | |
| Pubmed | 9.39e-12 | 7 | 120 | 5 | 22588126 | ||
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 9.39e-12 | 7 | 120 | 5 | 12383250 | |
| Pubmed | 9.39e-12 | 7 | 120 | 5 | 31906564 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CLTCL1 SYNE1 HMGB2 PPFIA3 CCDC6 YWHAB YWHAH YWHAZ PSMD6 CNNM1 LRPPRC SF3B3 GYS1 RRP12 DUSP16 YLPM1 YWHAQ | 1.52e-11 | 573 | 120 | 17 | 28330616 |
| Pubmed | 2.50e-11 | 8 | 120 | 5 | 16045749 | ||
| Pubmed | 2.50e-11 | 8 | 120 | 5 | 18332103 | ||
| Pubmed | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 5.60e-11 | 9 | 120 | 5 | 16888623 | |
| Pubmed | 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). | 5.60e-11 | 9 | 120 | 5 | 12438239 | |
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 5.60e-11 | 9 | 120 | 5 | 16511560 | |
| Pubmed | 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains. | 5.60e-11 | 9 | 120 | 5 | 34294877 | |
| Pubmed | 5.60e-11 | 9 | 120 | 5 | 16581770 | ||
| Pubmed | Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. | 1.12e-10 | 10 | 120 | 5 | 14505491 | |
| Pubmed | 1.12e-10 | 10 | 120 | 5 | 20478393 | ||
| Pubmed | Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. | 1.12e-10 | 10 | 120 | 5 | 15791647 | |
| Pubmed | 1.12e-10 | 10 | 120 | 5 | 12433946 | ||
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 1.12e-10 | 10 | 120 | 5 | 25154416 | |
| Pubmed | Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. | 1.12e-10 | 10 | 120 | 5 | 11697890 | |
| Pubmed | 1.35e-10 | 4 | 120 | 4 | 8515476 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CEP85 PLOD3 STUB1 CIP2A TM9SF3 PSTPIP2 YWHAB YWHAH YWHAZ CDKAL1 PSMD6 LRPPRC DUSP16 ANKRD17 YWHAQ TMED10 SEC63 HECTD1 PTPN20 SFN | 1.52e-10 | 974 | 120 | 20 | 28675297 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CEP85 STUB1 SYNE1 CIP2A KTN1 TM9SF3 MRPL19 GDI2 YWHAB YWHAH YWHAZ CDKAL1 PSMD6 LRPPRC NOP14 SQSTM1 FBXO28 RRP12 GLS PRKCQ YWHAQ TMED10 ARHGEF2 SEC63 | 2.75e-10 | 1496 | 120 | 24 | 32877691 |
| Pubmed | 3.49e-10 | 12 | 120 | 5 | 39406751 | ||
| Pubmed | BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. | 3.49e-10 | 12 | 120 | 5 | 29686263 | |
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 3.49e-10 | 12 | 120 | 5 | 19172738 | |
| Pubmed | CEP85 PLOD3 CIP2A PSTPIP2 PPFIA3 CCDC6 YWHAB YWHAH YWHAZ PSMD6 CNNM1 NOP14 RRP12 DUSP16 YLPM1 FBXO33 YWHAQ ARHGEF2 PTPN20 AURKB | 5.53e-10 | 1049 | 120 | 20 | 27880917 | |
| Pubmed | 5.66e-10 | 13 | 120 | 5 | 22222486 | ||
| Pubmed | 5.66e-10 | 13 | 120 | 5 | 19014373 | ||
| Pubmed | CYP2A13 CLTCL1 SYNE1 KTN1 TM9SF3 DUOX2 HMGB2 YWHAB YWHAH YWHAZ LRPPRC TNRC18 SF3B3 NOP14 SUSD1 GLS YLPM1 KIF5C YWHAQ ARHGEF2 BSN OBI1 SFN | 7.67e-10 | 1442 | 120 | 23 | 35575683 | |
| Pubmed | 8.78e-10 | 14 | 120 | 5 | 16093354 | ||
| Pubmed | 8.78e-10 | 14 | 120 | 5 | 12919677 | ||
| Pubmed | SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. | 8.78e-10 | 14 | 120 | 5 | 33761321 | |
| Pubmed | PDE4B KALRN SYNE1 KTN1 PPFIA3 CCDC6 GDI2 YWHAB TENM2 YWHAH YWHAZ LRPPRC YLPM1 ANKRD17 KIF5C YWHAQ TMED10 ARHGEF2 BSN | 8.92e-10 | 963 | 120 | 19 | 28671696 | |
| Pubmed | 1.31e-09 | 15 | 120 | 5 | 23572552 | ||
| Pubmed | Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. | 1.31e-09 | 15 | 120 | 5 | 16041367 | |
| Pubmed | SYNE1 KTN1 LAMA3 YWHAB YWHAH GFAP YWHAZ JUN DUSP16 ANKRD17 YWHAQ MAP2K5 OBI1 COG4 | 1.56e-09 | 486 | 120 | 14 | 20936779 | |
| Pubmed | 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. | 2.01e-09 | 6 | 120 | 4 | 11864996 | |
| Pubmed | 2.01e-09 | 6 | 120 | 4 | 16672277 | ||
| Pubmed | Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. | 2.01e-09 | 6 | 120 | 4 | 10713667 | |
| Pubmed | The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent. | 2.01e-09 | 6 | 120 | 4 | 19860830 | |
| Pubmed | Interactome dynamics of RAF1-BRAF kinase monomers and dimers. | 2.69e-09 | 17 | 120 | 5 | 37045861 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CCDC6 HNF4A NXN YWHAB JMJD1C YWHAZ SMYD2 PSMD6 LRPPRC SF3B3 PIK3C3 SQSTM1 RASGRP3 GYS1 RRP12 KIF5C YWHAQ ARHGEF2 SEC63 USP15 OBI1 | 3.00e-09 | 1284 | 120 | 21 | 17353931 |
| Pubmed | PLOD3 CLTCL1 STUB1 DDX60 CIP2A KTN1 TM9SF3 YWHAB YWHAH YWHAZ CDKAL1 PSMD6 LRPPRC SF3B3 SQSTM1 RRP12 CNOT7 YWHAQ TMED10 ARHGEF2 SEC63 COG4 | 4.16e-09 | 1440 | 120 | 22 | 30833792 | |
| Pubmed | 4.68e-09 | 7 | 120 | 4 | 10441394 | ||
| Pubmed | 4.68e-09 | 7 | 120 | 4 | 10620507 | ||
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 4.68e-09 | 7 | 120 | 4 | 36096339 | |
| Pubmed | 4.68e-09 | 7 | 120 | 4 | 16868027 | ||
| Pubmed | SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. | 4.68e-09 | 7 | 120 | 4 | 19640509 | |
| Pubmed | 4.68e-09 | 7 | 120 | 4 | 21390248 | ||
| Pubmed | 7.05e-09 | 42 | 120 | 6 | 23444366 | ||
| Pubmed | 9.33e-09 | 8 | 120 | 4 | 15708996 | ||
| Pubmed | Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. | 9.33e-09 | 8 | 120 | 4 | 9524113 | |
| Pubmed | Mouse thioredoxin gene maps on chromosome 4, whereas its pseudogene maps on chromosome 1. | 9.33e-09 | 8 | 120 | 4 | 8088797 | |
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 9.33e-09 | 8 | 120 | 4 | 23622247 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PLOD3 DDX60 TM9SF3 LAMA3 HMGB2 YWHAB YWHAH YWHAZ LRPPRC SF3B3 NOP14 SQSTM1 RRP12 GLS ANKRD17 YWHAQ ARHGEF2 SEC63 SFN AURKB | 1.18e-08 | 1257 | 120 | 20 | 36526897 |
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 1.68e-08 | 9 | 120 | 4 | 12176984 | |
| Pubmed | 1.68e-08 | 9 | 120 | 4 | 18458160 | ||
| Pubmed | 1.68e-08 | 9 | 120 | 4 | 12446771 | ||
| Pubmed | 1.86e-08 | 251 | 120 | 10 | 27507650 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CLTCL1 SYNE1 KTN1 HMGB2 GDI2 YWHAB YWHAH YWHAZ PSMD6 LRPPRC DUOX1 SF3B3 MYG1 ZFHX3 YWHAQ SFN | 2.01e-08 | 807 | 120 | 16 | 30575818 |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | CLTCL1 OXR1 CIP2A MRPL19 PSTPIP2 CCDC6 NXN YWHAB YWHAH YWHAZ DUSP16 YWHAQ TMED10 SEC63 PTPN20 SFN AURKB | 2.32e-08 | 931 | 120 | 17 | 27432908 |
| Pubmed | STUB1 MRPL19 NXN GDI2 YWHAB YWHAH GFAP YWHAZ PSMD6 LRPPRC SF3B3 PABPN1 GYS1 RRP12 YWHAQ TMED10 ARHGEF2 RIOK2 USP15 HECTD1 | 3.20e-08 | 1335 | 120 | 20 | 29229926 | |
| Pubmed | The structural basis for 14-3-3:phosphopeptide binding specificity. | 4.01e-08 | 3 | 120 | 3 | 9428519 | |
| Pubmed | 4.01e-08 | 3 | 120 | 3 | 8617504 | ||
| Pubmed | The BEACH-containing protein WDR81 coordinates p62 and LC3C to promote aggrephagy. | 4.37e-08 | 11 | 120 | 4 | 28404643 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | STUB1 TM9SF3 HJURP GDI2 YWHAB YWHAH YWHAZ CDKAL1 PSMD6 LRPPRC SF3B3 PABPN1 SQSTM1 YWHAQ TMED10 USP15 HECTD1 SFN AURKB | 6.41e-08 | 1257 | 120 | 19 | 37317656 |
| Pubmed | 6.53e-08 | 12 | 120 | 4 | 18779327 | ||
| Pubmed | 6.53e-08 | 12 | 120 | 4 | 20642453 | ||
| Pubmed | CIP2A HIP1R YWHAB YWHAH YWHAZ RRP12 YWHAQ TMED10 ARHGEF2 COG4 | 6.75e-08 | 288 | 120 | 10 | 23383273 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 6.98e-08 | 289 | 120 | 10 | 23752268 | |
| Pubmed | 9.41e-08 | 13 | 120 | 4 | 34654719 | ||
| Pubmed | 9.49e-08 | 225 | 120 | 9 | 25277244 | ||
| Pubmed | 1.01e-07 | 162 | 120 | 8 | 25796446 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 1.01e-07 | 162 | 120 | 8 | 14743216 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | VPS37A CEP85 PLOD3 STUB1 CIP2A KTN1 HMGB2 CCDC6 PSMD6 JUN LRPPRC SQSTM1 DUSP16 YLPM1 OBI1 AURKB | 1.24e-07 | 922 | 120 | 16 | 27609421 |
| Pubmed | PLOD3 SYNE1 HMGB2 EZH1 GDI2 YWHAB GFAP YWHAZ LRPPRC SF3B3 PABPN1 GLS KIF5C YWHAQ TMED10 | 1.24e-07 | 803 | 120 | 15 | 36517590 | |
| Pubmed | 1.25e-07 | 67 | 120 | 6 | 29357390 | ||
| Pubmed | 1.31e-07 | 14 | 120 | 4 | 15265780 | ||
| Pubmed | AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis. | 1.31e-07 | 14 | 120 | 4 | 36806887 | |
| Pubmed | Dermal fibroblasts influence the expression profile of 14-3-3 proteins in human keratinocytes. | 1.60e-07 | 4 | 120 | 3 | 21416292 | |
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 9705322 | ||
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 9408084 | ||
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 16968670 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CIP2A KTN1 TM9SF3 YWHAH CDKAL1 LRPPRC SQSTM1 RRP12 ANKRD17 YWHAQ TMED10 RFT1 ARHGEF2 SEC63 HECTD1 AURKB | 1.66e-07 | 942 | 120 | 16 | 31073040 |
| Pubmed | Quantitative interaction proteomics of neurodegenerative disease proteins. | TM9SF3 YWHAB YWHAH YWHAZ PSMD6 LRPPRC SQSTM1 CNOT7 YWHAQ TMED10 | 1.96e-07 | 323 | 120 | 10 | 25959826 |
| Pubmed | PCBP3 CLTCL1 OXR1 KTN1 HIP1R HMGB2 GDI2 RSBN1 LRPPRC SF3B3 ANKRD17 | 2.01e-07 | 411 | 120 | 11 | 36652389 | |
| Pubmed | 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle. | 2.38e-07 | 16 | 120 | 4 | 23071090 | |
| Pubmed | 2.74e-07 | 255 | 120 | 9 | 15324660 | ||
| Pubmed | PLOD3 STUB1 KTN1 HMGB2 GDI2 YWHAB YWHAH YWHAZ LRPPRC TNRC18 SF3B3 SQSTM1 ANKRD17 YWHAQ ARHGEF2 USP15 HECTD1 SFN | 2.91e-07 | 1247 | 120 | 18 | 27684187 | |
| Pubmed | 2.93e-07 | 257 | 120 | 9 | 31046837 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HJURP CCDC6 YWHAB YWHAH YWHAZ LRPPRC PIK3C3 SQSTM1 ANKRD17 KIF5C YWHAQ ARHGEF2 HECTD1 OBI1 SFN | 3.02e-07 | 861 | 120 | 15 | 36931259 |
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 3.91e-07 | 81 | 120 | 6 | 20697350 | |
| Pubmed | Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. | 3.97e-07 | 18 | 120 | 4 | 30240640 | |
| Pubmed | 3.99e-07 | 5 | 120 | 3 | 12364343 | ||
| Pubmed | Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. | 3.99e-07 | 5 | 120 | 3 | 19173300 | |
| Pubmed | Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms. | 3.99e-07 | 5 | 120 | 3 | 11886850 | |
| Pubmed | The Cdk-like protein PCTAIRE-1 from mouse brain associates with p11 and 14-3-3 proteins. | 3.99e-07 | 5 | 120 | 3 | 9197417 | |
| Pubmed | 3.99e-07 | 5 | 120 | 3 | 23938468 | ||
| Interaction | KCNK15 interactions | 3.34e-10 | 8 | 117 | 5 | int:KCNK15 | |
| Interaction | KCNK9 interactions | 7.48e-10 | 9 | 117 | 5 | int:KCNK9 | |
| Interaction | CEP192 interactions | FAM184A CEP85 CIP2A CCDC6 YWHAB YWHAH YWHAZ DUSP16 YWHAQ OBI1 SFN AURKB | 1.27e-09 | 192 | 117 | 12 | int:CEP192 |
| Interaction | BCR interactions | GABRR1 STUB1 RASA1 CCDC6 YWHAB YWHAH YWHAZ SQSTM1 GYS1 RRP12 YWHAQ USP15 SFN | 1.77e-09 | 244 | 117 | 13 | int:BCR |
| Interaction | PPP1R3D interactions | 2.33e-09 | 22 | 117 | 6 | int:PPP1R3D | |
| Interaction | CCSER1 interactions | 3.13e-09 | 23 | 117 | 6 | int:CCSER1 | |
| Interaction | GARRE1 interactions | FAM184A CEP85 YWHAB YWHAH YWHAZ DUSP16 CNOT7 ANKRD17 YWHAQ OBI1 SFN | 3.70e-09 | 167 | 117 | 11 | int:GARRE1 |
| Interaction | PPP1R3E interactions | 4.64e-09 | 12 | 117 | 5 | int:PPP1R3E | |
| Interaction | KCNK3 interactions | 7.50e-09 | 13 | 117 | 5 | int:KCNK3 | |
| Interaction | APC interactions | CEP85 RASA1 SYNE1 LAMA3 CCDC6 YWHAB YWHAH YWHAZ JUN ANKRD17 YWHAQ USP15 HECTD1 COG4 SFN | 7.76e-09 | 389 | 117 | 15 | int:APC |
| Interaction | MAP3K2 interactions | 9.94e-09 | 73 | 117 | 8 | int:MAP3K2 | |
| Interaction | SYNRG interactions | 1.24e-08 | 75 | 117 | 8 | int:SYNRG | |
| Interaction | PIK3C2B interactions | 2.00e-08 | 52 | 117 | 7 | int:PIK3C2B | |
| Interaction | MAP3K9 interactions | 2.20e-08 | 31 | 117 | 6 | int:MAP3K9 | |
| Interaction | SAMSN1 interactions | 2.51e-08 | 16 | 117 | 5 | int:SAMSN1 | |
| Interaction | CEP112 interactions | 2.70e-08 | 32 | 117 | 6 | int:CEP112 | |
| Interaction | EXPH5 interactions | 3.40e-08 | 56 | 117 | 7 | int:EXPH5 | |
| Interaction | FAM53B interactions | 4.88e-08 | 18 | 117 | 5 | int:FAM53B | |
| Interaction | FAM163A interactions | 6.59e-08 | 19 | 117 | 5 | int:FAM163A | |
| Interaction | TMCC3 interactions | 9.39e-08 | 39 | 117 | 6 | int:TMCC3 | |
| Interaction | SIPA1L2 interactions | 9.92e-08 | 136 | 117 | 9 | int:SIPA1L2 | |
| Interaction | SPIRE2 interactions | 1.14e-07 | 21 | 117 | 5 | int:SPIRE2 | |
| Interaction | STOX2 interactions | 1.14e-07 | 21 | 117 | 5 | int:STOX2 | |
| Interaction | DENND1B interactions | 1.14e-07 | 21 | 117 | 5 | int:DENND1B | |
| Interaction | PPP4R4 interactions | 1.47e-07 | 22 | 117 | 5 | int:PPP4R4 | |
| Interaction | ARHGEF28 interactions | 1.49e-07 | 42 | 117 | 6 | int:ARHGEF28 | |
| Interaction | WDR62 interactions | 1.64e-07 | 104 | 117 | 8 | int:WDR62 | |
| Interaction | AKAP11 interactions | 1.64e-07 | 104 | 117 | 8 | int:AKAP11 | |
| Interaction | SSH2 interactions | 1.72e-07 | 43 | 117 | 6 | int:SSH2 | |
| Interaction | LUZP1 interactions | 1.98e-07 | 194 | 117 | 10 | int:LUZP1 | |
| Interaction | OTOG interactions | 2.21e-07 | 10 | 117 | 4 | int:OTOG | |
| Interaction | E2F8 interactions | 2.35e-07 | 24 | 117 | 5 | int:E2F8 | |
| Interaction | PACS2 interactions | 2.35e-07 | 24 | 117 | 5 | int:PACS2 | |
| Interaction | CEP131 interactions | 2.63e-07 | 200 | 117 | 10 | int:CEP131 | |
| Interaction | BECN1 interactions | YWHAB YWHAH MEFV JUN LRPPRC PIK3C3 SQSTM1 USP15 MAP2K5 HECTD1 | 2.75e-07 | 201 | 117 | 10 | int:BECN1 |
| Interaction | C6orf132 interactions | 2.93e-07 | 25 | 117 | 5 | int:C6orf132 | |
| Interaction | TMCC1 interactions | 2.93e-07 | 25 | 117 | 5 | int:TMCC1 | |
| Interaction | PDPK1 interactions | 3.01e-07 | 203 | 117 | 10 | int:PDPK1 | |
| Interaction | TRAK1 interactions | 3.19e-07 | 77 | 117 | 7 | int:TRAK1 | |
| Interaction | EGLN3 interactions | CEP85 PLOD3 STUB1 CIP2A TM9SF3 HJURP CCDC6 YWHAB JMJD1C YWHAZ CDKAL1 PSMD6 JUN LRPPRC SQSTM1 CNOT7 ANKRD17 YWHAQ TMED10 RIOK2 USP15 HECTD1 OBI1 AURKB | 3.43e-07 | 1296 | 117 | 24 | int:EGLN3 |
| Interaction | CDCA7 interactions | 3.45e-07 | 11 | 117 | 4 | int:CDCA7 | |
| Interaction | MAST4 interactions | 3.61e-07 | 26 | 117 | 5 | int:MAST4 | |
| Interaction | FAM83G interactions | 3.61e-07 | 26 | 117 | 5 | int:FAM83G | |
| Interaction | SIK3 interactions | 3.81e-07 | 79 | 117 | 7 | int:SIK3 | |
| Interaction | CEP95 interactions | 4.34e-07 | 50 | 117 | 6 | int:CEP95 | |
| Interaction | SPIRE1 interactions | 4.41e-07 | 27 | 117 | 5 | int:SPIRE1 | |
| Interaction | RAP1GAP interactions | 4.90e-07 | 51 | 117 | 6 | int:RAP1GAP | |
| Interaction | GNGT2 interactions | 5.15e-07 | 12 | 117 | 4 | int:GNGT2 | |
| Interaction | KIAA0930 interactions | 5.35e-07 | 28 | 117 | 5 | int:KIAA0930 | |
| Interaction | USP31 interactions | 5.35e-07 | 28 | 117 | 5 | int:USP31 | |
| Interaction | WWC2 interactions | 5.35e-07 | 28 | 117 | 5 | int:WWC2 | |
| Interaction | DENND2B interactions | 5.35e-07 | 28 | 117 | 5 | int:DENND2B | |
| Interaction | CEP170B interactions | 5.35e-07 | 83 | 117 | 7 | int:CEP170B | |
| Interaction | MAP7D3 interactions | 5.99e-07 | 123 | 117 | 8 | int:MAP7D3 | |
| Interaction | SORBS1 interactions | 5.99e-07 | 123 | 117 | 8 | int:SORBS1 | |
| Interaction | ZNF629 interactions | 5.99e-07 | 123 | 117 | 8 | int:ZNF629 | |
| Interaction | NUB1 interactions | 6.18e-07 | 53 | 117 | 6 | int:NUB1 | |
| Interaction | FAM13A interactions | 6.43e-07 | 29 | 117 | 5 | int:FAM13A | |
| Interaction | KLC2 interactions | 7.31e-07 | 172 | 117 | 9 | int:KLC2 | |
| Interaction | ZFP36L1 interactions | 7.68e-07 | 30 | 117 | 5 | int:ZFP36L1 | |
| Interaction | ARAP2 interactions | 7.68e-07 | 30 | 117 | 5 | int:ARAP2 | |
| Interaction | TICRR interactions | 7.68e-07 | 30 | 117 | 5 | int:TICRR | |
| Interaction | FBXO45 interactions | 7.99e-07 | 88 | 117 | 7 | int:FBXO45 | |
| Interaction | ANKRD17 interactions | 8.07e-07 | 226 | 117 | 10 | int:ANKRD17 | |
| Interaction | HSP90AA1 interactions | RAG1 CEP85 STUB1 DDX60 KTN1 YWHAB YWHAH YWHAZ SMYD2 JUN AREL1 LRPPRC SF3B3 MYG1 PIK3C3 PABPN1 SQSTM1 FBXO28 PRKCQ YWHAQ MAP2K5 AURKB BRWD1 | 8.43e-07 | 1263 | 117 | 23 | int:HSP90AA1 |
| Interaction | FOXO1 interactions | STUB1 CCDC6 HNF4A YWHAB YWHAH GFAP YWHAZ LRPPRC SF3B3 SQSTM1 YWHAQ SFN | 8.52e-07 | 347 | 117 | 12 | int:FOXO1 |
| Interaction | KIF5B interactions | KTN1 CCDC6 YWHAB YWHAH YWHAZ PSMD6 LRPPRC SQSTM1 KIF5C YWHAQ SFN AURKB | 8.79e-07 | 348 | 117 | 12 | int:KIF5B |
| Interaction | PABIR1 interactions | 9.11e-07 | 31 | 117 | 5 | int:PABIR1 | |
| Interaction | DOCK11 interactions | 9.59e-07 | 57 | 117 | 6 | int:DOCK11 | |
| Interaction | GCKR interactions | 1.03e-06 | 14 | 117 | 4 | int:GCKR | |
| Interaction | EXO1 interactions | 1.06e-06 | 58 | 117 | 6 | int:EXO1 | |
| Interaction | FRYL interactions | 1.06e-06 | 58 | 117 | 6 | int:FRYL | |
| Interaction | DLGAP1 interactions | 1.07e-06 | 180 | 117 | 9 | int:DLGAP1 | |
| Interaction | AKT1S1 interactions | 1.08e-06 | 32 | 117 | 5 | int:AKT1S1 | |
| Interaction | CDR2L interactions | 1.34e-06 | 95 | 117 | 7 | int:CDR2L | |
| Interaction | CLASP1 interactions | 1.44e-06 | 138 | 117 | 8 | int:CLASP1 | |
| Interaction | KCNQ5 interactions | 1.47e-06 | 34 | 117 | 5 | int:KCNQ5 | |
| Interaction | REEP3 interactions | 1.47e-06 | 34 | 117 | 5 | int:REEP3 | |
| Interaction | YWHAQ interactions | PDE4B STUB1 HJURP CCDC6 YWHAB YWHAH YWHAZ MEFV LRPPRC PIK3C3 PABPN1 RASGRP3 DUSP16 ANKRD17 PRKCQ KIF5C YWHAQ ARHGEF2 HECTD1 SFN AURKB | 1.68e-06 | 1118 | 117 | 21 | int:YWHAQ |
| Interaction | SMTNL2 interactions | 1.71e-06 | 35 | 117 | 5 | int:SMTNL2 | |
| Interaction | FAM86C1P interactions | 1.71e-06 | 35 | 117 | 5 | int:FAM86C1P | |
| Interaction | MAP3K20 interactions | 1.78e-06 | 99 | 117 | 7 | int:MAP3K20 | |
| Interaction | TRIM32 interactions | 1.91e-06 | 193 | 117 | 9 | int:TRIM32 | |
| Interaction | KIAA1671 interactions | 1.99e-06 | 194 | 117 | 9 | int:KIAA1671 | |
| Interaction | MYO9A interactions | 2.03e-06 | 101 | 117 | 7 | int:MYO9A | |
| Interaction | CNOT4 interactions | 2.10e-06 | 65 | 117 | 6 | int:CNOT4 | |
| Interaction | HTT interactions | RASA1 HIP1R CASP6 PPFIA3 YWHAB YWHAH GFAP YWHAZ PSMD6 ACOT11 SQSTM1 RAB30 DUSP16 CNOT7 KIF5C YWHAQ ARHGEF2 BSN SFN | 2.23e-06 | 949 | 117 | 19 | int:HTT |
| Interaction | ING1 interactions | 2.32e-06 | 103 | 117 | 7 | int:ING1 | |
| Interaction | ZNF395 interactions | 2.42e-06 | 17 | 117 | 4 | int:ZNF395 | |
| Interaction | NAV1 interactions | 2.55e-06 | 149 | 117 | 8 | int:NAV1 | |
| Interaction | SMG7 interactions | CEP85 CCDC6 JMJD1C NOP14 SQSTM1 RRP12 DUSP16 CNOT7 YLPM1 ANKRD17 OBI1 | 2.57e-06 | 319 | 117 | 11 | int:SMG7 |
| Interaction | PFKFB4 interactions | 2.61e-06 | 38 | 117 | 5 | int:PFKFB4 | |
| Interaction | TNK1 interactions | 2.61e-06 | 38 | 117 | 5 | int:TNK1 | |
| Interaction | RUSC2 interactions | 2.61e-06 | 38 | 117 | 5 | int:RUSC2 | |
| Interaction | CYLD interactions | FAM184A PLOD3 STUB1 KTN1 CCDC6 YWHAB YWHAH YWHAZ PSMD6 JUN SF3B3 PIK3C3 SQSTM1 FBXO33 YWHAQ USP15 SFN AURKB | 2.61e-06 | 868 | 117 | 18 | int:CYLD |
| Interaction | CCDC18 interactions | 2.75e-06 | 68 | 117 | 6 | int:CCDC18 | |
| Interaction | TANC1 interactions | 2.81e-06 | 106 | 117 | 7 | int:TANC1 | |
| Interaction | PRR5 interactions | 2.98e-06 | 39 | 117 | 5 | int:PRR5 | |
| Interaction | SHROOM1 interactions | 3.10e-06 | 18 | 117 | 4 | int:SHROOM1 | |
| Interaction | TTC28 interactions | 3.19e-06 | 108 | 117 | 7 | int:TTC28 | |
| Cytoband | 10p15 | 1.41e-04 | 7 | 120 | 2 | 10p15 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 3.76e-11 | 7 | 83 | 5 | 1053 | |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 1.31e-06 | 172 | 120 | 8 | M8234 | |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_UP | 3.90e-06 | 199 | 120 | 8 | M8399 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN | 4.04e-06 | 200 | 120 | 8 | M9408 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 4.04e-06 | 200 | 120 | 8 | M9458 | |
| Coexpression | GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN | 4.04e-06 | 200 | 120 | 8 | M6184 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 5.78e-06 | 26 | 120 | 4 | M1380 | |
| Coexpression | PKCA_DN.V1_UP | 8.87e-06 | 159 | 120 | 7 | M2755 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | STUB1 KTN1 SLCO3A1 HMGB2 YWHAB YWHAH JUN TNRC18 ZFHX3 TMED10 | 1.41e-05 | 394 | 120 | 10 | MM3724 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 3.46e-05 | 269 | 120 | 8 | M41203 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 3.90e-05 | 200 | 120 | 7 | M9411 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP | 3.90e-05 | 200 | 120 | 7 | M9944 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN | 3.90e-05 | 200 | 120 | 7 | M7868 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP | 3.90e-05 | 200 | 120 | 7 | M5623 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | PDE4B OXR1 KALRN MRPL19 CCDC6 YWHAB YWHAH YWHAZ SMYD2 PSMD6 CNNM1 LRPPRC GLS CNOT7 KIF5C BSN USP15 | 5.47e-05 | 1248 | 120 | 17 | M17728 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 6.54e-05 | 380 | 120 | 9 | M45714 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.11e-04 | 54 | 120 | 4 | MM927 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.11e-04 | 54 | 120 | 4 | M2372 | |
| Coexpression | ESC_J1_UP_LATE.V1_DN | 1.27e-04 | 168 | 120 | 6 | M2765 | |
| Coexpression | ESC_V6.5_UP_LATE.V1_DN | 1.84e-04 | 180 | 120 | 6 | M2771 | |
| Coexpression | GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP | 2.14e-04 | 185 | 120 | 6 | M5643 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_DN | 2.15e-04 | 64 | 120 | 4 | M40914 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | CIP2A HJURP MRPL19 YWHAZ CDKAL1 MYG1 PIK3C3 PABPN1 GYS1 CNOT7 KICS2 SFN | 2.37e-04 | 776 | 120 | 12 | M1107 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 2.65e-04 | 458 | 120 | 9 | M40010 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP | 2.76e-04 | 194 | 120 | 6 | M4213 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | KTN1 MRPL19 SLC35G2 YWHAH NOP14 PABPN1 GLS CNOT7 RFT1 RIOK2 OBI1 AURKB | 2.85e-04 | 792 | 120 | 12 | M12113 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | CIP2A HJURP MRPL19 YWHAZ CDKAL1 MYG1 PIK3C3 PABPN1 GYS1 CNOT7 KICS2 SFN | 2.91e-04 | 794 | 120 | 12 | MM982 |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN | 2.92e-04 | 196 | 120 | 6 | M8717 | |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN | 3.00e-04 | 197 | 120 | 6 | M8227 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP | 3.08e-04 | 198 | 120 | 6 | M8041 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_UP | 3.08e-04 | 198 | 120 | 6 | M5207 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP | 3.08e-04 | 198 | 120 | 6 | M5591 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | 3.17e-04 | 199 | 120 | 6 | M3328 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN | 3.17e-04 | 199 | 120 | 6 | M7463 | |
| Coexpression | GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP | 3.17e-04 | 199 | 120 | 6 | M6192 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 3.17e-04 | 199 | 120 | 6 | M6108 | |
| Coexpression | GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 3.17e-04 | 199 | 120 | 6 | M8979 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP | 3.17e-04 | 199 | 120 | 6 | M2922 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN | 3.25e-04 | 200 | 120 | 6 | M8039 | |
| Coexpression | GSE27786_CD4_TCELL_VS_MONO_MAC_DN | 3.25e-04 | 200 | 120 | 6 | M4834 | |
| Coexpression | GSE17721_CTRL_VS_CPG_8H_BMDC_UP | 3.25e-04 | 200 | 120 | 6 | M3767 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_CULTURE_UP | 3.25e-04 | 200 | 120 | 6 | M7301 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP | 3.25e-04 | 200 | 120 | 6 | M9953 | |
| Coexpression | GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP | 3.25e-04 | 200 | 120 | 6 | M8514 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP | 3.25e-04 | 200 | 120 | 6 | M3901 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP | 3.25e-04 | 200 | 120 | 6 | M7760 | |
| Coexpression | GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP | 3.25e-04 | 200 | 120 | 6 | M4387 | |
| Coexpression | WENG_POR_DOSAGE | 3.47e-04 | 30 | 120 | 3 | MM1199 | |
| Coexpression | PROVENZANI_METASTASIS_UP | 3.61e-04 | 204 | 120 | 6 | M4100 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 3.61e-04 | 204 | 120 | 6 | M10688 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.53e-07 | 190 | 120 | 7 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-07 | 191 | 120 | 7 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-07 | 191 | 120 | 7 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.15e-07 | 192 | 120 | 7 | 9f12b79d661ef0f57c2c924e8ecc24a46ea996d2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.80e-07 | 194 | 120 | 7 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-06 | 196 | 120 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-06 | 198 | 120 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-06 | 198 | 120 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-06 | 198 | 120 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.20e-06 | 200 | 120 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.55e-06 | 164 | 120 | 6 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.59e-06 | 169 | 120 | 6 | dc388f660f69e37e517bf3243daf071ab138ee6e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.53e-06 | 173 | 120 | 6 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.04e-06 | 175 | 120 | 6 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.04e-06 | 175 | 120 | 6 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.04e-06 | 175 | 120 | 6 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.86e-06 | 178 | 120 | 6 | b1357ceb84b83fab53c0394c1af73cbd009f571a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.44e-06 | 180 | 120 | 6 | e76ccbaba18ff27abbd71a41fd3574a5ac5c8fb4 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.17e-05 | 187 | 120 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.21e-05 | 188 | 120 | 6 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.25e-05 | 189 | 120 | 6 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.32e-05 | 191 | 120 | 6 | efe0cb0b6602621f5eda72a723b83b38bf15607f | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.32e-05 | 191 | 120 | 6 | 00676c598f6dae0ff9158d064248f1265432f3e1 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.36e-05 | 192 | 120 | 6 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|World / disease group, cell group and cell class | 1.36e-05 | 192 | 120 | 6 | 3352f13a6e706991dcf3ec173587bb6aba36a385 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.36e-05 | 192 | 120 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 192 | 120 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.36e-05 | 192 | 120 | 6 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.36e-05 | 192 | 120 | 6 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.40e-05 | 193 | 120 | 6 | 32d139f922cd19adc1cc1e0e9a828115be9945d6 | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|COVID-19_Severe / disease group, cell group and cell class | 1.40e-05 | 193 | 120 | 6 | 45fe14c10b71459047608c8931d83c9c533f97f9 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.40e-05 | 193 | 120 | 6 | 91955c3773c9729a96e82f240f06b072367970d9 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-05 | 194 | 120 | 6 | 24f9de4781666c96c4a2d04f8a444543dbd99cbe | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 194 | 120 | 6 | a516839871c4e9683093a1c07b72c682f9ecbb3d | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-05 | 194 | 120 | 6 | 82753b90ca3b563275c41b6040ebbcd99b185e24 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.44e-05 | 194 | 120 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.44e-05 | 194 | 120 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 194 | 120 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-05 | 195 | 120 | 6 | 8f5a664dd65c38afe23c6acd0a9c22ba4fd347ed | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-05 | 195 | 120 | 6 | e830f0c545be87a1056a4505bdf6845e5ac7750d | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_naive|COVID-19_Severe / Disease group, lineage and cell class | 1.49e-05 | 195 | 120 | 6 | 71563e838fcda34a9a209c5433e0d84420373402 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 195 | 120 | 6 | a838bddeed487154791b69d27a68673783ff63c0 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.53e-05 | 196 | 120 | 6 | c87499aa570f8fab878c4c015e47c711a3a21e9c | |
| ToppCell | Healthy_donor-B_naive|Healthy_donor / disease group, cell group and cell class (v2) | 1.53e-05 | 196 | 120 | 6 | cf254b1466357984201595fa32408d659eb741ef | |
| ToppCell | primary_visual_cortex-Neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-05 | 196 | 120 | 6 | 8efc2b3a95f57c31be203ac781b2098d4909297f | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-05 | 196 | 120 | 6 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4|Liver / Manually curated celltypes from each tissue | 1.58e-05 | 197 | 120 | 6 | 4891111894b741555f549deec6af8006376d9358 | |
| ToppCell | mild_COVID-19-B_naive|World / disease group, cell group and cell class (v2) | 1.58e-05 | 197 | 120 | 6 | b817ecdcea453a15fd0dd1d7fdf196bed68f7358 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 197 | 120 | 6 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.67e-05 | 199 | 120 | 6 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.67e-05 | 199 | 120 | 6 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_naive|COVID-19_Severe / Disease, condition lineage and cell class | 1.72e-05 | 200 | 120 | 6 | 5ba9c541fa356d34f392a63274dcd7bfb844cbb6 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.72e-05 | 200 | 120 | 6 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 1.72e-05 | 200 | 120 | 6 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | ILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.72e-05 | 200 | 120 | 6 | 6ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4 | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.72e-05 | 200 | 120 | 6 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.72e-05 | 200 | 120 | 6 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.59e-05 | 145 | 120 | 5 | 1e52e3c615b49e7388cd58a04e74cafac9552447 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.74e-05 | 146 | 120 | 5 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 154 | 120 | 5 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 6.50e-05 | 156 | 120 | 5 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 157 | 120 | 5 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.90e-05 | 158 | 120 | 5 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-05 | 162 | 120 | 5 | 80619a93c57fe16daf91dc571874ef9ac888953d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.99e-05 | 163 | 120 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.48e-05 | 169 | 120 | 5 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.48e-05 | 169 | 120 | 5 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.48e-05 | 169 | 120 | 5 | 50cc0f5a022b95986949db63208a627cef9f4a69 | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 1.00e-04 | 171 | 120 | 5 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Il33_(Il33)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 90 | 120 | 4 | 091bbcceecb7b5c30b92e0c991bb117561b43b89 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Il33_(Il33)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 90 | 120 | 4 | 5046bb6a66ce138c5c1dc4060d1360d494a91a67 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 177 | 120 | 5 | 8dfadd9852e0c256363471a7cfe6af120c8c51e0 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 177 | 120 | 5 | 767b2af5f224d100b22bed32f86cec1cd17e8711 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 177 | 120 | 5 | 5ef2527e9b41e62f1724cdabaad9d8979266bb7d | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 177 | 120 | 5 | b41e975e8368e2618b015be095efe8c0e001c78b | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 177 | 120 | 5 | ae1d2fdd4f67f50c906b27ea084de058c6908aa2 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 177 | 120 | 5 | 15d1de38e4f1a0d4a786d83ee92240f44bdff006 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.21e-04 | 178 | 120 | 5 | a34bb693b72684cbd97ac9efff77d2d14e41be75 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-04 | 178 | 120 | 5 | 5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb | |
| ToppCell | Control-Lymphocyte-B-B_naive|Control / Disease, Lineage and Cell Type | 1.24e-04 | 179 | 120 | 5 | 35994281904bfe38766e715ab608211a5ca865a9 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 179 | 120 | 5 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 180 | 120 | 5 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 180 | 120 | 5 | ff34195bb7325e61fbf823c103c5e6115d8f1248 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 181 | 120 | 5 | 477c572c5c1efceee49732cc9e8b1dad68a7e6e5 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 181 | 120 | 5 | 909280b44085d8e96fcd3cbcba6bff94badd41e8 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 181 | 120 | 5 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 181 | 120 | 5 | 9275531e896e118cee043ed94fd31a0070d9581c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-04 | 182 | 120 | 5 | 862cc68006918e9e46e22b236302d862737f1061 | |
| ToppCell | Influenza_Severe-B_naive|World / Disease group and Cell class | 1.34e-04 | 182 | 120 | 5 | e4885a5e6065c9c403cb2d305228691d6ae4ecb6 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 182 | 120 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.38e-04 | 183 | 120 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.38e-04 | 183 | 120 | 5 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | Healthy/Control-CD4+_CTL|Healthy/Control / Disease group and Cell class | 1.41e-04 | 184 | 120 | 5 | 6c6ffa150f81e456f88e9065de90c2dcda417589 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 184 | 120 | 5 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 120 | 5 | 282b3de8850f3c21704339e8d8737b432a43441a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 120 | 5 | ff598af88c7f9d7224cc4ed96b1c3463ef76b550 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 120 | 5 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 185 | 120 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | IIF-Lymphocyte-B-B_naive|IIF / Disease, Lineage and Cell Type | 1.45e-04 | 185 | 120 | 5 | dec48908addfc71f32f5ce0ce73f2926e476f60b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-04 | 186 | 120 | 5 | 993c58ef4445bf81bbc9b489635883848b5b4c8e | |
| Disease | smoking behavior | 7.12e-05 | 341 | 118 | 8 | EFO_0004318 | |
| Disease | phenylketonuria (implicated_via_orthology) | 9.46e-05 | 4 | 118 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 1.32e-04 | 477 | 118 | 9 | C0005586 | |
| Disease | Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome | 1.57e-04 | 5 | 118 | 2 | C0263859 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.37e-04 | 75 | 118 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | endometrial carcinoma (is_marker_for) | 3.41e-04 | 34 | 118 | 3 | DOID:2871 (is_marker_for) | |
| Disease | smoking cessation | 3.42e-04 | 325 | 118 | 7 | EFO_0004319 | |
| Disease | N-acetylcarnosine measurement | 4.37e-04 | 8 | 118 | 2 | EFO_0022101 | |
| Disease | body height at birth | 5.53e-04 | 40 | 118 | 3 | EFO_0006784 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 5.60e-04 | 9 | 118 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | economic and social preference | 6.32e-04 | 97 | 118 | 4 | EFO_0004827 | |
| Disease | Alcoholic Intoxication, Chronic | 7.48e-04 | 268 | 118 | 6 | C0001973 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.00e-03 | 49 | 118 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | risk-taking behaviour | PDE4B CASP6 CCDC6 TENM2 YWHAZ LRPPRC ATAD2B RRP12 ZFHX3 FBXO33 | 1.01e-03 | 764 | 118 | 10 | EFO_0008579 |
| Disease | Drug habituation | 1.19e-03 | 115 | 118 | 4 | C0013170 | |
| Disease | Drug abuse | 1.19e-03 | 115 | 118 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.19e-03 | 115 | 118 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.19e-03 | 115 | 118 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.19e-03 | 115 | 118 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.19e-03 | 115 | 118 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.19e-03 | 115 | 118 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.19e-03 | 115 | 118 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.19e-03 | 115 | 118 | 4 | C0029231 | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.20e-03 | 13 | 118 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | Substance abuse problem | 1.23e-03 | 116 | 118 | 4 | C0740858 | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 1.40e-03 | 14 | 118 | 2 | DOID:627 (is_implicated_in) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 1.40e-03 | 14 | 118 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | asthma, body mass index | 1.40e-03 | 14 | 118 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | Body Weight | 1.61e-03 | 15 | 118 | 2 | C0005910 | |
| Disease | insulin resistance | 1.72e-03 | 59 | 118 | 3 | EFO_0002614 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 1.83e-03 | 16 | 118 | 2 | OBA_2045195 | |
| Disease | smoking behaviour measurement | 2.03e-03 | 222 | 118 | 5 | EFO_0005671 | |
| Disease | lifestyle measurement | 2.59e-03 | 235 | 118 | 5 | EFO_0010724 | |
| Disease | Omenn Syndrome | 2.59e-03 | 19 | 118 | 2 | C2700553 | |
| Disease | age at menarche | 2.72e-03 | 594 | 118 | 8 | EFO_0004703 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.78e-03 | 145 | 118 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | glaucoma (is_marker_for) | 2.87e-03 | 20 | 118 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Severe Combined Immunodeficiency | 2.87e-03 | 20 | 118 | 2 | C0085110 | |
| Disease | chronotype measurement | 2.89e-03 | 882 | 118 | 10 | EFO_0008328 | |
| Disease | basophil percentage of leukocytes | 2.99e-03 | 243 | 118 | 5 | EFO_0007992 | |
| Disease | juvenile idiopathic arthritis | 3.29e-03 | 74 | 118 | 3 | EFO_0002609 | |
| Disease | brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement | 3.48e-03 | 22 | 118 | 2 | EFO_0004277, EFO_0006790, EFO_0006792, EFO_0006797, EFO_0006798 | |
| Disease | blood pressure | 3.48e-03 | 22 | 118 | 2 | EFO_0004325 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 3.48e-03 | 22 | 118 | 2 | EFO_0021115 | |
| Disease | unipolar depression, bipolar disorder | 3.62e-03 | 156 | 118 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Drugs used in diabetes use measurement | 3.67e-03 | 255 | 118 | 5 | EFO_0009924 | |
| Disease | citrate measurement | 3.95e-03 | 79 | 118 | 3 | EFO_0010114 | |
| Disease | Liver Cirrhosis, Experimental | 3.96e-03 | 774 | 118 | 9 | C0023893 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSRDSSELLEDMMIE | 491 | Q8NAT2 | |
| MECYMDSEEFEKLVS | 316 | Q6PI77 | |
| DDMPRSADYFMQEAK | 971 | P51826 | |
| EQAERYDDMAAAMKA | 16 | P31946 | |
| AERYDDMATCMKAVT | 16 | P27348 | |
| TDYQMTKRDMGFTEE | 306 | P00813 | |
| REEAMSAYITEMKLV | 81 | Q8NC06 | |
| QAERYDDMASAMKAV | 16 | Q04917 | |
| AERYEDMAAFMKGAV | 16 | P31947 | |
| DYSSEDMDVEMALKR | 826 | Q6L9W6 | |
| VTMEEYFMRETVNKA | 421 | Q9H9E3 | |
| EIIKMFDERMAYYTS | 1446 | Q07092 | |
| VIYSELMSDFEMDEK | 196 | Q92974 | |
| SEMEYDREKPMVYTS | 4851 | Q6V0I7 | |
| ISTKLFMEKERMEYF | 931 | A2A2Z9 | |
| YTLEDDKFLSFHMEM | 416 | Q8WXI4 | |
| ESSLEMDDERYFNEM | 326 | Q16204 | |
| SECMRYIATITDKEM | 1416 | O75179 | |
| MDYAFSDLMRDRSAA | 501 | Q96SC8 | |
| VSLEEMEEKYLMRES | 971 | Q8NB25 | |
| ENTSYRMEEKSDFML | 726 | Q8NCD3 | |
| RYDSALVSALMDMEE | 561 | P15918 | |
| DEMYEQVRKSLEMCS | 246 | Q9H939 | |
| MSMEDYDFLFKIVLI | 1 | Q15771 | |
| RYSMEKIMPEEEYSE | 711 | P20936 | |
| MSKEEVDRYNFVMLA | 396 | Q96AA3 | |
| AMDMEQRDYDSRTAL | 576 | O94925 | |
| EETAVFMKYAENIML | 231 | Q7Z5J8 | |
| SPEEKSRLMFRMYDF | 851 | Q9NRD9 | |
| ADREDMIIMFVDSYD | 101 | O60568 | |
| IGRFSEEEIYMLMEK | 251 | Q5TGI0 | |
| YKRMTGSEFDFEEMK | 421 | P50395 | |
| LMNARYFLEMSDTKD | 116 | Q04759 | |
| YFLEMSDTKDMNEFE | 121 | Q04759 | |
| MSRIAMYELLADADI | 1006 | Q16787 | |
| EMEAMKTICQSFREY | 866 | Q6ZRS4 | |
| MTAKMETTFYDDALN | 1 | P05412 | |
| EDMAKSDKARYDREM | 61 | P26583 | |
| SEEDSMVGTLYDKMY | 151 | Q9HB07 | |
| RSYFMESLVDARMLD | 971 | O75145 | |
| TDTEFENMDMYSRVK | 221 | Q9ULI0 | |
| QDMDVERSVSDLYKM | 1066 | Q15652 | |
| SGEDFKTMMPARYED | 2266 | Q15652 | |
| LKSAEEAYEEMMRKA | 1181 | Q9UPA5 | |
| EENMTETDAFYKREM | 16 | P55212 | |
| FSDALDEYNMKIMED | 1521 | Q8IY21 | |
| DEYNMKIMEDFTTFL | 1526 | Q8IY21 | |
| PEDKSRLMFTMYDLD | 856 | Q9NRD8 | |
| SKDEFFTMMRSFIEI | 876 | Q9NRD8 | |
| RVYIMAFDIKSEDML | 371 | Q7Z6M2 | |
| MRLSKTLVDMDMADY | 1 | P41235 | |
| KLDDVTDEYLMSMYG | 26 | Q96MB7 | |
| TVRSDEEMKAMLSYY | 71 | Q13163 | |
| YMRPDTTFSEDKMVA | 256 | Q8NH73 | |
| SVMTVMADDNVKDYF | 6 | Q07343 | |
| FTEEEEQLSRKMMKY | 476 | O00748 | |
| LKTFDMEDEYMLGSA | 706 | Q8TET4 | |
| MEEKVAFYIRDIMEA | 2776 | O60229 | |
| DAAYLDKISELDSMM | 531 | Q5W0B1 | |
| RIFEKMFAMTLEESA | 546 | P55160 | |
| MELEKAEMERSTYVT | 1211 | Q86UP2 | |
| LLMSEDYFTQAMEVK | 1076 | P42704 | |
| TKYFSETLRSEMEMF | 571 | O15553 | |
| AEMMELNDRFASYIE | 71 | P14136 | |
| DAYDMMVRELGFEMK | 251 | P78316 | |
| MIAYKFEEDIINSMS | 106 | P57721 | |
| YLMDLSYSMKDDLER | 156 | P26010 | |
| RMEIADFYEKMYTLS | 136 | Q96MD2 | |
| EEKTAAYDIMQEFMA | 151 | Q4JDL3 | |
| EEVMSAAMYKEILDS | 266 | Q8N573 | |
| MSIEEKMEADARSIY | 161 | Q86U42 | |
| TARMEMLIEELYAFM | 421 | Q8NA61 | |
| MREMFFEDHIDDAKY | 241 | Q9UIV1 | |
| SMMVASKYLYDEGEE | 126 | Q9BV87 | |
| TVEMFDYMDCELKLS | 176 | O75146 | |
| TYTIMYREMKDSDKE | 1871 | Q9ULT8 | |
| ISEVDMDFTMTLYLR | 111 | P24046 | |
| FDYEDKEFLSLLRMM | 191 | Q16696 | |
| SDSVLMEMKREYCVA | 326 | Q5VV42 | |
| KYMADMDELFSQVDE | 206 | Q9UNE7 | |
| FDYEDKEFLSLLSMM | 191 | P20853 | |
| KRMDMSLDEAYRFVK | 261 | Q9BY84 | |
| EDLRTTMSDRYAQDM | 741 | Q6P2H3 | |
| RDISSMAMEYFDEKI | 201 | Q9NVF7 | |
| DDLYMMDIFSEVMGR | 126 | Q92819 | |
| NDMSEMELVFAEEKY | 616 | O15033 | |
| YSMTLRLSALFEEKM | 1401 | Q9NSI6 | |
| DKEDFTMMKRAIFAT | 421 | P13807 | |
| ISEVDMDFTMTLYLR | 91 | P28476 | |
| GESEIRDAMMAKAEY | 96 | Q15008 | |
| SMSATMAEIYRDYKD | 96 | Q9BXW4 | |
| MEMERFSEEFLALTF | 386 | Q5VWQ0 | |
| AMESEQAMLSEREYE | 296 | Q9UIG8 | |
| AQADEMDRMKKEYTD | 701 | Q8NF91 | |
| YSTESLMEEMARADR | 251 | P0C7N4 | |
| QYSTESLMEEMARAD | 251 | A6NGB0 | |
| EEEFTMARLYISKMK | 581 | O60282 | |
| TILDMSARAKYVMDV | 396 | Q6DKJ4 | |
| FLLVDEKMAYVDMAT | 211 | Q8TBE7 | |
| DGLISKDEMMAYFLR | 466 | Q8IV61 | |
| ESEKRSSNFMYLMVE | 206 | Q8NEB9 | |
| FYAMDTLVMKTEENS | 1001 | Q9NT68 | |
| KETETEYFAALMTTM | 141 | Q5JTH9 | |
| EELTMAMSYVKDDIF | 81 | Q13501 | |
| AERYDDMAACMKSVT | 16 | P63104 | |
| DIMDVYEMKLSTLAS | 621 | Q8TCG1 | |
| DKYEEYDNAVLTMMS | 1366 | P53675 | |
| YLRMEELAFTQEEMT | 856 | Q9NRU3 | |
| RTATIMEELADALMY | 176 | Q96GD4 | |
| EFDMMREYDTSKIEA | 266 | P49406 | |
| MYAMKSSLEDMDALE | 1466 | O15417 | |
| MKSSTYEELDRVMIE | 71 | Q4W5G0 | |
| IVNDFAYMKKREEEM | 161 | P49755 | |
| SIKTADMEEMYLFHI | 511 | Q6UWL2 | |
| DDMKERYRELTEMSD | 251 | Q92800 | |
| MDENLSSIMERDDIY | 536 | Q9Y4E8 | |
| QYASMKEESVFRESM | 116 | Q8N945 | |
| MFMRIAKAYAALTDE | 141 | Q9UGP8 | |
| EYTERKEMSADVVCM | 576 | Q15393 | |
| YMSRDDFRVLTAVEM | 11 | Q9BVS4 | |
| YEAEMEETYRTSMFK | 1901 | P49750 | |
| DYARYSKEEEMDDMD | 251 | Q9HD45 | |
| EKMSSVFEDSNVYML | 326 | Q9NRG4 | |
| KMEIDDFLSSFMEKR | 356 | Q8NEZ2 | |
| TKAAMMAMSEYEDRL | 2876 | Q15911 |